Valeant Pharmaceuticals gets default notice from debt holder

Shares of Valeant Pharmaceuticals International Inc. fell in after-hours trading on Tuesday as the company said it has received a default notice from a debt holder. The default notice was filed by Centerbridge Partners LP, the Wall Street Journal reported. Shares of Valeant, which finished the regular trading session at $31.99 US, dipped as much as eight per cent in the after-hours session before recovering to trade off about three per cent.